Molecular Subtyping and Precision Medicine for Pancreatic Cancer

by Fieke E.M. Froeling, Raffaella Casolino, Antonio Pea, Andrew V. Biankin, David K. Chang
Published 2021-01-01

RhoC interacts with integrin α5β1 and enhances its trafficking in migrating pancreatic carcinoma cells.

by Ningfeng Fiona Li, Emilios Gemenetzidis, Francis J Marshall, Derek Davies, Yongwei Yu, Kristopher Frese, Fieke E M Froeling, Adam K Woolf, Roger M Feakins, Yoshiki Naito, Christine Iacobuzio-Donahue, David A Tuveson, Ian R Hart, Hemant M Kocher
Published 2013-01-01

Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer

by Hemant M. Kocher, Bristi Basu, Fieke E. M. Froeling, Debashis Sarker, Sarah Slater, Dominic Carlin, Nandita M. deSouza, Katja N. De Paepe, Michelle R. Goulart, Christine Hughes, Ahmet Imrali, Rhiannon Roberts, Maria Pawula, Richard Houghton, Cheryl Lawrence, Yathushan Yogeswaran, Kelly Mousa, Carike Coetzee, Peter Sasieni, Aaron Prendergast, David J. Propper
Published 2020-09-01